Liu et al., 2019 - Google Patents
Combination of [12] aneN3 and triphenylamine-benzylideneimidazolone as nonviral gene vectors with two-photon and AIE propertiesLiu et al., 2019
- Document ID
- 2867461236166941344
- Author
- Liu M
- Ma L
- Liu X
- Liu J
- Lu Z
- Liu R
- He L
- Publication year
- Publication venue
- ACS applied materials & interfaces
External Links
Snippet
Three nonviral gene vectors, TPA-BI-A/B/C, have been designed and synthesized by the combination of one or two hydrophilic [12] aneN3 moieties and two-photon fluorescent triphenylamine-benzylideneimidazolone (TPA-BI) units through different ester linkage …
- -1 Triphenylamine-Benzylideneimidazolone 0 title abstract description 17
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Combination of [12] aneN3 and triphenylamine-benzylideneimidazolone as nonviral gene vectors with two-photon and AIE properties | |
| Zuo et al. | Fluorine-doped cationic carbon dots for efficient gene delivery | |
| Cutler et al. | Polyvalent oligonucleotide iron oxide nanoparticle “click” conjugates | |
| Biju et al. | FRET from quantum dots to photodecompose undesired acceptors and report the condensation and decondensation of plasmid DNA | |
| He et al. | AIE featured inorganic–organic core@ shell nanoparticles for high-efficiency siRNA delivery and real-time monitoring | |
| Ma et al. | Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissions | |
| Huang et al. | CRISPR spherical nucleic acids | |
| Wang et al. | Aggregation-induced emission luminogen-embedded silica nanoparticles containing DNA aptamers for targeted cell imaging | |
| Li et al. | A DNA tetrahedron nanoprobe with controlled distance of dyes for multiple detection in living cells and in vivo | |
| Fakhoury et al. | Development and characterization of gene silencing DNA cages | |
| Song et al. | Peptide-conjugated fluorescent silicon nanoparticles enabling simultaneous tracking and specific destruction of cancer cells | |
| Chu et al. | Fluorescent silicon nanorods-based ratiometric sensors for long-term and real-time measurements of intracellular pH in live cells | |
| Jiao et al. | Cyclodextrin-based peptide self-assemblies (Spds) that enhance peptide-based fluorescence imaging and antimicrobial efficacy | |
| Cheng et al. | Dual-stimulus-responsive fluorescent supramolecular prodrug for antitumor drug delivery | |
| Chen et al. | Theranostic prodrug vesicles for imaging guided codelivery of camptothecin and siRNA in synergetic cancer therapy | |
| Majumdar et al. | Carbon-dot-coated alginate beads as a smart stimuli-responsive drug delivery system | |
| Chen et al. | Oxidation and acid milieu-disintegratable nanovectors with rapid cell-penetrating helical polymer chains for programmed drug release and synergistic chemo-photothermal therapy | |
| Xu et al. | Self-assembled ATP-responsive DNA nanohydrogel for specifically activated fluorescence imaging and chemotherapy in cancer cells | |
| Shi et al. | A simple, pH-activatable fluorescent aptamer probe with ultralow background for bispecific tumor imaging | |
| Ge et al. | Rational construction of protein-mimetic nano-switch systems based on secondary structure transitions of synthetic polypeptides | |
| Ghosh et al. | Lipid nanoparticle-mediated induction of endoplasmic reticulum stress in cancer cells | |
| Sun et al. | Two-photon fluorescent nanoprobe for glutathione sensing and imaging in living cells and zebrafish using a semiconducting polymer dots hybrid with dopamine and β-cyclodextrin | |
| Zhang et al. | In vivo and in situ activated aggregation-induced emission probes for sensitive tumor imaging using tetraphenylethene-functionalized trimethincyanines-encapsulated liposomes | |
| Hsieh et al. | Graphene oxide based nanocarrier combined with a pH-sensitive tracer: a vehicle for concurrent pH sensing and pH-responsive oligonucleotide delivery | |
| Zhang et al. | Multifunctional probe based on cationic conjugated polymers for nitroreductase-related analysis: sensing, hypoxia diagnosis, and imaging |